Busulfan-melphalan in high-risk neuroblastoma: the 30-year experience of a single institution.

Item

http://www.wikidata.org/entity/Q39865674

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Busulfan-melphalan in high-ris ...... ience of a single institution.

@en

Busulfan-melphalan in high-ris ...... ience of a single institution.

@nl

type

Item

label

Busulfan-melphalan in high-ris ...... ience of a single institution.

@en

Busulfan-melphalan in high-ris ...... ience of a single institution.

@nl

prefLabel

Busulfan-melphalan in high-ris ...... ience of a single institution.

@en

Busulfan-melphalan in high-ris ...... ience of a single institution.

@nl

P1476

Busulfan-melphalan in high-ris ...... ience of a single institution.

@en

P2093

C Dufour

http://www.w3.org/2001/XMLSchema#string

C Pasqualini

http://www.w3.org/2001/XMLSchema#string

D Valteau-Couanet

http://www.w3.org/2001/XMLSchema#string

E Benhamou

http://www.w3.org/2001/XMLSchema#string

G Goma

http://www.w3.org/2001/XMLSchema#string

M-A Raquin

http://www.w3.org/2001/XMLSchema#string

O Hartmann

http://www.w3.org/2001/XMLSchema#string

P Blanchard

http://www.w3.org/2001/XMLSchema#string

S Proust-Houdemont

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study

Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.

Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trial.

Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial.

NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology.

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN study.

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

High dose melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group.

Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.

P2888

bmt.2016.75

P304

1076-1081

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2016.75

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michaela Semeraro

P577

2016-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27042850

http://www.w3.org/2001/XMLSchema#string